Abstract
HIV treatment guidelines state that patients’ readiness should be assessed before initiating highly active antiretroviral therapy (HAART) to assure adherence. None of the guidelines provide a way to measure readiness. Therefore, this article sought to review the literature on readiness to determine if there was a viable predictor of adherence. Twenty-seven articles were reviewed. Nine described studies that examined the relationship between a measure of readiness and HAART adherence. No readiness measure demonstrated clinical utility as a predictor of adherence. Study flaws included small sample sizes (only one study >100 patients), short follow-up periods (all ≤1 year and six were ≤5 months, four ≤1 month), measures of readiness that related poorly to adherence, and inconsistent adherence measures (eight different measures were used by the researchers). Neither the guidelines nor the literature will help clinicians judge who should initiate HAART and who should delay treatment.
Similar content being viewed by others
References
Papers of particular interests, published recently, have been highlighted as: • Of importance •• Of major importance
Gazzard BG, Anderson J, Babiker A, et al.: British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008, 9:563–608.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1–161. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed May 10, 2010.
Hammer SM, Eron Jr JJ, Reiss P, et al.: Antiretroviral treatment of adult HIV infection — 2008 recommendations of the International AIDS Society–USA Panel. JAMA 2008, 300:555–570.
Clumeck N, Dedes N, Pozniak A, Raffi F, and the EACS Executive Committee: Guidelines, clinical management and treatment of HIV infected adults in Europe. Available at http://www.europeanaidsclinicalsociety.org/guidelines.asp. Accessed May 10, 2010.
Catalan J, Collins P, Mash B, Freeman M: Psychotherapeutic interventions in antiretroviral therapy: for second level care. Available at http://whqlibdoc.who.int/publications/2005/9241593091_eng.pdf. Accessed May 10, 2010.
Bangsberg DR, Perry S, Charlebois ED, et al.: Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001, 15:1181–1183.
Gross R, Yip B, Lo Re V 3rd, et al.: A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006, 194:1108–1114.
Paterson DL, Swindells S, Mohr J, et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133:21–30.
•• Nordqvist O, Sodergard B, Tully MP, et al.: Assessing and achieving readiness to initiate HIV medication. Patient Educ Couns 2006, 62:21–30. This is an excellent review of the early studies and essays on readiness. It was a starting point for our review.
Prochaska J, DiClemente C: Stages and process of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol 1983, 51:390–395.
Highstein GR, Willey C, Mundy LM: Development of stage of readiness and decisional balance instruments: tools to enhance clinical decision-making for adherence to antiretroviral therapy. AIDS Behav 2006, 10:563–573.
Rathbun RC, Farmer KC, Lockhart SM, Stephens JR: Validity of a state of change instrument in assessing medication in indigent patients with HIV infection. Ann Pharmacother 2007, 41920:208–214.
Willey C, Redding C, Stafford J, et al.: Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2000, 22:858–871.
• Gardner L, Marks G, Metsch LR, et al.: Psychological and Behavioral Correlates of Entering Care for HIV Infection: The Antiretroviral Treatment Access Study (ARTAS). AIDS Patient Care STDS 2007, 21:418–425. This is the largest study that examined readiness to enter care. It was based on the stages of change model and provides some useful insights into why individuals delay seeking care.
• Enriquez M, Cheng A-L, McKinsey DS, Stanford J: Development and efficacy of an intervention to enhance readiness for adherence among adults who had previously failed HIV treatment. AIDS Patient Care STDS 2009, 23:177–184. This an intriguing study in that it used an intervention on 28 patients who had failed at least four previous regimens. The intervention was either six or 12 sessions to help patients become “ready” to resume HAART (readiness was not defined or measured). Fourteen of these patients had undetectable viral loads at 3 months, and 11 had undetectable viral loads at 12 months.
• Balfour L, Tasca GA, Kowal J, et al.: Development and validation of the HIV medication readiness scale. Assessment 2007, 14:408–416. This study tested a 10-item HIV readiness scale that was found to be predictive of adherence after 1 month of treatment. The short follow-up and the use of two measures of self-report to define adherence raise caution flags. However, it is an approach that should be replicated in patients who will be followed for a longer period of time.
Fowler ME: Recognizing the phenomenon of readiness: concept analysis and case study. J Assoc Nurs AIDS Care 1998, 9:72–76.
Enriquez M, Gore PA, O’Connor MC, McKinsey DS: Assessment of readiness for adherence by HIV-positive males who had previously failed treatment. J Assoc Nurs AIDS Care 2004, 15:42–49.
Sodergard B, Halvarsson M, Lindback S, et al.: Differences in adherence and motivation to HIV therapy—two independent assessments in 1998 and 2002. Pharm World Sci 2006, 28:248–256.
Sodergard B, Hofer S, Halvarsson M, et al.: A structural equation modeling approach to the concepts of adherence and readiness in antiretroviral treatment. Patient Educ Counsel 2007, 67:108–116.
Tessema B, Fantahun B, Andargachew A, et al.: Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: A cross sectional study. AIDS Res Ther 2010, 7:1–8.
Fleury JD: Empowering potential: a theory of wellness motivation. Nurs Res 1991, 40:286–291.
Gebrekristos HT, Mlisana K, Karim KA: Patient readiness to start highly active antiretroviral Therapy for HIV. BMJ 2005, 331:772–774.
Weiss L, French T, Finkelstein R, et al.: HIV-related knowledge and adherence to HAART. AIDS Care 2003, 15:673–679.
Balfour L, Kowal J, Tasca GA, et al.: Development and psychometric validation of the HIV Treatment Knowledge Scale. AIDS Care 2007, 19:1141–1148.
Cooper V, Buick D, Horner R, et al.: Perceptions of HAART among gay men who declined a treatment offer: preliminary results from an interview-based study. AIDS Care 2002, 14:319–328.
Gellaitry G, Cooper V, Davis C, et al.: Patients’ perception of information about HAART: Impact on treatment decisions. AIDS Care 2005, 17:367–376.
Gold R, Ridge DT: “I will start treatment when I think the time is right”: HIV-positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001, 13:693–708.
Fehr JS, Nicca D, Sendi P, et al.: Starting or changing therapy—a prospective study exploring antiretroviral decision-making. Infection 2005, 33:249–256.
Morgenstern TT, Grimes DE, Grimes RM: Pilot study: assessment of readiness to initiate antiretroviral therapy. HIV Clin Trials 2002, 3:168–172.
Kremer H, Ironson G, Schneiderman N, HautZinger M: To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDs 2006, 20:335–349.
•• Grimes RM, Grimes DE: Patient readiness to adhere to HAART. J Int Assoc Phys AIDS Care 2009, 8:364–366. This study demonstrated that asking patients if they think they are ready has no predictive value at all. It did not matter whether patients were naïve to HAART or restarting after a greater than 6 month “drug holiday.” It suggests that future studies along this line are likely to be futile.
Balfour L, Kowal J, Silverman S, et al.: A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Car 2006, 18:830–838.
Alfonso V, Bermbach N, Geller J, Montaner JS: Individual variability in barriers affecting people’s decision to take HAART: A qualitative study identifying barriers to being on HAART. AIDS Patient Care STDs 2006, 20:848–857.
Sidat M, Fairley C, Grierson J: Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study. AIDS Patient Care STDs 2007, 21:509–520.
• Wagner G, Iguchi M, Schneider S, et al.: Placebo practice trials: a tool to assess and improve adherence readiness. HIV Clin Trials 2002, 3:475–481. In this study, 20 patients took placebos for a 2-week trial and were monitored by electronic devices until they showed that they could adhere at >90%. This took up to five trials for some patients. Of the 15 patients who achieved “readiness,” 87% achieved >90% adherence.
• Wagner G: Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clin Trials 2003, 4:269–281. This was a follow-up trial using the methods from reference 36. A total of 201 patients, most with a history of substance abuse, were enrolled and 181 completed at least one trial. Eighty-three patients started HAART and only 33 achieved >90% adherence during a 2-week follow-up period.
Enriquez M, Lackey NR, O’Connor MC, McKinsey DS: Successful adherence after multiple HIV treatment failures. J Adv Nurs 2004, 45:438–446.
Golin CE, Liu H, Hays RD, et al.: A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002, 17:756–765.
Holzemer WL, Bakken S, Portillo CJ, et al.: Testing a nurse-tailored HIV medication adherence intervention. Nurs Res 2006, 55:189–197.
Wise J, Operario D: Use of electronic reminder devices to improve adherence to antiretroviral therapy: A systematic review. AIDS Patient Care STDs 2008, 22:495–504.
Acknowledgment
This study was supported by the Baylor-UT Houston Center for AIDS Research (CFAR), a National Institutes of Health–funded program (AI036211).
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grimes, R.M., Grimes, D.E. Readiness: The State of the Science (or the Lack Thereof). Curr HIV/AIDS Rep 7, 245–252 (2010). https://doi.org/10.1007/s11904-010-0056-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-010-0056-2